Related Experiment Video
Updated: Jan 3, 2026

An Affordable HIV-1 Drug Resistance Monitoring Method for Resource Limited Settings
Published on: March 30, 2014
Repositioning Implementation Science in the HIV Response: Looking Ahead From AIDS 2018
James Hargreaves1, Shona Dalal2, Brian Rice1
1Faculty of Public Health and Policy, London School of Hygiene and Tropical Medicine, London, United Kingdom.
Implementation science (IS) is advancing HIV/AIDS research, but primary HIV prevention requires more rigorous studies. Addressing data weaknesses and incorporating costing are crucial for future progress in HIV/AIDS prevention and treatment.
Area of Science:
- Implementation science
- HIV/AIDS research
- Public health interventions
Background:
- Implementation science (IS) is vital for translating evidence-based HIV interventions into real-world impact.
- IS research is a dedicated track at the International AIDS Conference, highlighting its importance.
- The goal of IS is to improve HIV prevention, testing, treatment, quality of life, and mortality rates.
Purpose of the Study:
- To review the content of Track E and related presentations on IS at the 22nd International AIDS Conference (2018).
- To identify key findings and themes in HIV/AIDS implementation science.
- To provide recommendations for strengthening the field by the 2020 conference.
Main Methods:
- Content analysis of presentations from the 22nd International AIDS Conference (Amsterdam, 2018).
- Focus on Track E and other sessions relevant to implementation science in HIV/AIDS.
- Thematic identification and synthesis of key findings and challenges.
Main Results:
- "Treat all" strategies in Africa yielded mixed results.
- HIV testing innovations like self-testing and index testing are improving reach, especially among men.
- Adherence clubs and other retention strategies show mixed effectiveness.
- Pre-exposure prophylaxis implementation faces challenges in demand creation and sustained use.
Conclusions:
- Implementation science for HIV/AIDS treatment and prevention is growing.
- Prioritizing IS for primary HIV prevention is essential due to a lack of rigorous studies.
- Routine data quality, costing/financing studies, and addressing methodological challenges are key areas for development.
More Related Videos
07:18High Throughput In Vitro Assessment of Latency Reversing Agents on HIV Transcription and Splicing
Published on: January 22, 2019
10:29Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
Related Concept Videos
Retrovirus Life Cycles
Sexually Transmitted Infections
Size and Structure of Viral Genomes